Real-world outcomes of rivaroxaban treatment in elderly Japanese patients with nonvalvular atrial fibrillation

In conclusion, safety and effectiveness event rates were higher in patients aged ≥ 75 years compared w ith those aged <  75 years, yet, no distinct differences were observed among the 3 elderly sub-populations.
Source: Heart and Vessels - Category: Cardiology Source Type: research